Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
RVNC - As of  05/21/24, 03:30:40 AM:   20 Insider Transactions.

Sector: Healthcare    Industry: Biotechnology
Prev Close:$13.25  Avg Vol(3m): 303,200  P/E: 0.00  EPS: -3.07

Email this page to a friend.    Insider Transactions for RVNC

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
B 2020-08-10 09:43:11.0 Revance Therapeutics RVNC GIC Private Ltd 5.21% view
S 2020-02-06 09:10:28.0 Revance Therapeutics RVNC FRANKLIN RESOURCES INC 6.7% view
S 2020-01-17 10:33:17.0 Revance Therapeutics RVNC WELLINGTON MANAGEMENT GROUP LLP 11.44% view
B 2019-11-12 11:27:57.0 Revance Therapeutics RVNC Bank of New York Mellon Corp 4.81% view
S 2019-02-13 14:39:32.0 Revance Therapeutics RVNC Essex Woodlands Health Ventures VIII 9.04% view
B 2019-02-12 11:36:23.0 Revance Therapeutics RVNC WELLINGTON MANAGEMENT GROUP LLP 11.66% view
B 2019-02-06 17:28:18.0 Revance Therapeutics RVNC BlackRock Inc 6.89% view
B 2019-01-28 15:40:35.0 Revance Therapeutics RVNC FRANKLIN RESOURCES INC 10.2% view
S 2018-04-10 11:03:12.0 Revance Therapeutics RVNC WELLINGTON MANAGEMENT GROUP LLP 10.52% view
B 2018-02-09 09:37:06.0 Revance Therapeutics RVNC ArrowMark Colorado Holdings LLC 9.84% view
S 2018-02-07 15:10:34.0 Revance Therapeutics RVNC Bank of New York Mellon Corp 5.9% view
S 2018-01-25 14:09:56.0 Revance Therapeutics RVNC BlackRock Inc 6.0% view
B 2017-02-13 10:22:13.0 Revance Therapeutics RVNC FRANKLIN RESOURCES INC 11.5% view
S 2017-02-08 13:05:24.0 Revance Therapeutics RVNC NovaQuest Pharma Opportunities Fund III 6.81% view
B 2017-01-25 17:23:52.0 Revance Therapeutics RVNC BlackRock Inc 12.0% view
S 2016-02-12 12:44:32.0 Revance Therapeutics RVNC Essex Woodlands Health Ventures VIII 11.3% view
B 2016-02-09 12:42:31.0 Revance Therapeutics RVNC BlackRock Inc 5.6% view
B 2016-01-26 14:56:56.0 Revance Therapeutics RVNC Bank of New York Mellon Corp 10.4% view
B 2015-12-07 16:07:13.0 Revance Therapeutics RVNC JPMORGAN CHASE & CO 13.1% view
B 2015-02-13 16:29:53.0 Revance Therapeutics RVNC Visium Asset Management 11.6% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.